The European medicines regulator said that a higher rate of death and disease complications in recent trials meant the ...

Omeros Corporation maintained with Strong Buy rating after securing a $2.1 billion partnership with Novo Nordisk for ...

For patients with myelofibrosis who had anemia at diagnosis and received erythropoiesis-stimulating agents (ESAs) or danazol ...

About PYRUKYND® (mitapivat) U.S. INDICATION PYRUKYND is a pyruvate kinase activator indicated for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency.

Vonjo (pacritinib) improves hemoglobin levels in myelofibrosis patients with anemia, aligning with clinical guidelines for ...

It’s 7:30 a.m. at Kenneth Gill Stadium, and McDaniel football is scrimmaging during a crisp October morning. The Green Terror ...

In 2024, regulators approved Casgevy, the first CRISPR-based therapy to treat sickle cell disease and beta-thalassemia — a ...

Kelsey Soffer doesn’t like being told No. Take, for example, having a baby. Soffer, 34, was told that she would never ...

Researchers led by Masako Tamaki at the RIKEN Center for Brain Science in Japan report a link between deep sleep and cerebrospinal fluid, the clear liquid that surrounds and supports the brain and ...

An epidemic of Type 2 diabetes continues to plague the United States, leading to calls for reassessing how the disease is ...

Research suggests that exercising later in the day may help people with type 2 diabetes better manage blood glucose.

You probably aren't drinking enough water, and Kohler's newest device tells you so -- from your toilet. Kohler unveiled Dekoda, a sensor that attaches to a toilet to monitor hydration, gut health, ...